Science in Service
of
Medicineresult
President & CEO Letter
2025 Annual Metrics
Cycle of Translation
Visionary Gifts of Hope
Introduction
Ann Kimball and John W. Johnson Center for Cellular Therapeutics at Houston Methodist
Houston Methodist Dr. Mary and Ron Neal Cancer Center
The Food & Health Alliance within the Houston Methodist Lynda K. and David M. Underwood Center for Digestive Disorders, Immunology Center and the Fondren Inflammation Collaborative
Houston Methodist Cockrell Center for Advanced Therapeutics
Paula and Joseph C. “Rusty” Walter III Translational Research Initiative
Jerold B. Katz Academy of Translational Research
Infectious Diseases Research Fund
George and Angelina Kostas Research Center for Cardiovascular Medicine
New Endowed Chairs Positions
EnMed
Center for Bioenergetics
From Discovery to Clinic
What is "Discovery to Clinic"?
Clinical Research
Houston Methodist Conducts First-Ever Study into a Challenging Situation
Can Regulating Cellular Aging Mitigate Both Cancer and Heart Disease?
Innovative Treatment for Chronic Rhinitis is Safe and Effective
Masters of Disguise: Glioblastomas Trick the Immune System by Masquerading as Reproductive Tissue
Improved Options for Patients with Severe Retinal Vascular Disease
A New FDA-Approved Treatment for Sufferers of Chronic Constipation
Houston Methodist joins the Gulf Coast Consortia
Outcomes, Quality and Healthcare Performance
New Findings on RNA Helicases May Yield New Intestinal Disease Therapy
Houston Methodist and Pennsylvania State University Collaborate on a Smartphone App That Could Revolutionize Stroke Diagnosis
New Frontiers to Improve Cardiovascular Medicine and Disease Management
Ongoing Lessons in a Pandemic
Transplants can Boost Survival Rate of Patients with Unresectable Liver Cancers
Telehealth Video Visits During the COVID-19 Pandemic – a Glimpse into the Future?
SARS-CoV-2 Induced Chronic Oxidative Stress and Endothelial Cell Inflammation May Increase Likelihood of Cardiovascular Diseases and Respiratory Failure
Restorative Medicine
Lessening Pain After Knee Replacement Surgery
Do Motor Neurons First Die in the Brain? Study Provides Clues about ALS Origins
Bringing Back Hand Function in People with Complete Spinal Cord Injury
Novel Vascular Engineering Platforms Are a Boon for Bioengineering
Ultra-high-Resolution Scanner Reveals if Knee Injury Advances to Osteoarthritis
Houston Methodist Model Demonstrates Reversal from Heart Failure State, Creating the Potential for Innovative Treatment Avenues
Precision Medicine
Rapidly Scalable, All-Inducible Neural Organoids Could Facilitate Drug Screening for Neurological Diseases
Importance of the Coronary Artery Calcium Score in Risk Assessment and Prevention of Atherosclerotic Cardiovascular Disease
COVID-19 Infection in Crucial Brain Regions May Lead To Accelerated Brain Aging
Interleukin 9 Secreting Polarized T Cells Show Potential in Solid and Liquid Tumor Treatment
The NanoLymph: Implantable. Adaptable. Anti-cancer
Science in Service
of
MedicineFrom the President
2025 Annual Metrics
Cycle of Translation
result
Share This Story
From The President
Science in Service of Health
From The President
Science in Service of Health
From The President
Science in Service of Health

It is with great pleasure to share our 2025 Annual Report highlighting notable achievements of the Houston Methodist Academic Institute.
Philanthropist John F. Bookout, Jr. presented a vision, “Houston Methodist will be for the southern United States what is now found on the two coasts and in the Midwest—a leading academic medical center.”
Twenty years later, this vision is realized. The Houston Methodist Academic Institute continues its trajectory of success that followed investing in the visionary ideas of our Centers of Excellence. And they delivered by increasing grant funding from $10M annually to more than $100M annually over 10 years.
This success momentum is even stronger. We accepted the challenge at the confluence of uncertainty and probability in science, which is part of our dedicated mission through a global collaborative network that transitions proof-of-concept medical research into clinical impact and educates health care professionals on the latest medical breakthroughs in the service of health.
We know Houston Methodist excels in clinical quality and safety outcomes today, but we exist in a constantly changing landscape that requires innovation with science-based programs, such as Sepsis Early Recognition and Response Initiative (SERRI), focused on improving the early identification and treatment of sepsis, a life-threatening condition caused by infection, to truly lead. SERRI put Houston Methodist on the map as the academic medical center that developed early sepsis screening tools that interfaced with our electronic health records and training programs that helped 15 health systems save $50 million in medical costs and 2,500 lives.
Houston Methodist is home to the first coronary artery bypass graft and the first multi-organ transplant. Its innovative education programs, such as new translational PhD programs in medicinal chemistry with Rice University and the Texas A&M University EnMed physician engineering school, the quality and safety certifications envisioned, and extended reality simulation education technology being developed at the Bookout Center.
Our 2040 Vision Impact charts our National Impact Initiatives for Transforming Care Now through Quality & Safety Innovation, Digital Health, Science Implementation and Transforming Future Patient Care with Healthspan Research, Gene Modulation & Bioengineered Therapeutics, Robotics & Imaging.
It is an honor to be on this journey for what lies ahead for Houston Methodist’s future of medicine and human health.
Jenny C. Chang, MB.ChirB., MD, MCHM
Ernest Cockrell, Jr. Presidential Distinguished Chair
Executive Vice President and Chief Academic Officer
Houston Methodist
President and CEO, Houston Methodist Academic Institute
Houston Methodist Academic Institute Board Members
Judge Ewing Werlein, Jr., Senior Chair
W. Benjamin Moreland, Chair
Edward R. Allen, III
Steven Birdwell
John F. Bookout, III
Marc L. Boom, MD
P. Embry Canterbury
Jenny C. Chang, MD
David Chao
Martin Craighead
Leslie Doggett
Elaine Finger
Antonio Gotto, MD, D.Phil
Robert A. Harrington, MD
Edward A. Jones
Evan H. Katz
Sippi K. Khurana, MD
Steven Looke
Ransom Lummis
David A. Modesett
James Muschalik
Gregory Nelson
Joe Bob Perkins
Ward Sheffield
Jeffrey F. Simmons
Suzanne (Sue) Smith
Christopher G. Stavros
Steven D. Stephens
Spencer A. Tillman
David M. Underwood, Jr.
Amy Waer, MD
Martha Walton
Donna Sims Wilson
Vision for the Second Century
The Houston Methodist Vision for the Second Century advances the initiatives of utmost importance to the hospital while placing our patients at the center of everything we do. It illustrates the emphasis placed on our academic medicine mission, which includes restorative medicine, precision medicine, outcomes research, clinical research, and innovative education. These elements are supported by the fundamental values and initiatives of Houston Methodist, which define our commitment to advance the practice of medicine and offer our patients leading care.